Global COPD Drugs Market Forecast to 2023 COPD Market Report | Page 2

Scope of the Report – COPD Drugs Market
Forecast
Historical
2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
          
          
          
ICS
Others
Combination
Therapy
Anticholiner
gics
Beta-
Agonist 
 
 
 
 
 
 
 
 
 
 

          
          
          
ICS           
Others
Combination
Therapy
Anticholiner
gics
Beta-
Agonist           
          
          
          
ICS           
Market (By Value)
By Drugs Type,
By Value
By Drugs Type,
By Value
By Drugs Type,
By Value
By Company
Combination
Therapy
Anticholiner
gics
Beta-
Agonist
Others











Glaxo SmithKline, AstraZeneca, Boehringer-Ingelheim, TEVA Pharmaceuticals, Chiesi Pharmaceuticals, Novartis, Merck, Cipla, Mylan, Vectura,
and Sunovion.
By Region North America, Europe, APAC, and ROW.
By Country US, Canada, UK, Germany, France, Italy, China, Japan, India, Rest of the world.
(c) AZOTH Analytics
2